Intra-articular BPC-157 for multiple types of knee pain
Among 16 contacted patients, 11/12 receiving BPC-157 alone reported significant improvement; uncontrolled and subjective.
What this study tells us
Researchers looked back at outcomes without randomly assigning treatment. This can reveal real-world patterns, but it is weaker for proving that the treatment itself caused the result.
Patients receiving intra-articular BPC-157 for knee pain
n=17
Among 16 contacted patients, 11/12 receiving BPC-157 alone reported significant improvement; uncontrolled and subjective.
No randomization, blinding or validated outcome scales; tiny sample; selection/recall bias; cannot establish efficacy.
Need help with terms such as randomized, placebo, endpoint or sample size? Open the glossary →
Key result
Among 16 contacted patients, 11/12 receiving BPC-157 alone reported significant improvement; uncontrolled and subjective.